(5-207) Comparison of Standard Dose versus Reduced Dose Apixaban for Atrial Fibrillation in Patients with End-Stage Renal Disease Receiving Hemodialysis

Monday, December 5, 2022

4:15 PM – 5:15 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Cardiology/Anticoagulation

Co-Author(s): Emma Studlack

Primary Author(s)

Sandra Labib
PharmD Candidate Class of 2023
D'youville School of Pharmacy, New York